Graf Akcie CRL (Charles River Laboratories International Inc.). Diskuze k akciím CRL. Aktuální informace CRL.

Základní informace o společnosti Charles River Laboratories International Inc. (Akcie CRL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 20.93B
Hodnota podniku (EV) 24.68B
Tržby 3.273B
EBITDA 640.985M
Zisk 396.078M
Růst v tržbách Q/Q 33.99 %
Růst v tržbách Y/Y 19.09 %
P/E (Cena vůči ziskům) 51.53
Forward P/E 0.66
EV/Sales 7.54
EV/EBITDA 38.50
EV/EBIT 41.49
PEG 2.08
Price/Sales 6.40
P/FCF 43.25
Price/Book 9.90
Účetní hodnota na akcii 41.33
Hotovost na akcii 4.46
FCF vůči ceně 2.31 %
Počet zaměstnanců 18,400
Tržba na zaměstnance 177.906k
Profit margin 12.46 %
Operating margin 15.97 %
Gross margin 36.72 %
EBIT margin 18.17 %
EBITDA margin 19.58 %
EPS - Zisk na akcii 7.94
EPS - Kvartální růst 65.19 %
EPS - Očekávaný růst příští rok 10.73 %
Return on assets 6.82 %
Return on equity 18.61 %
ROIC 10.52 %
ROCE 10.27 %
Dluhy/Equity 1.58
Čistý dluh/EBITDA 13.24
Current ratio 1.36
Quick Ratio 1.15
Volatilita 2.99
Beta 1.06
RSI 42.17
Cílová cena analytiků 261
Známka akcie (dle analytiků) 1.47
Insider ownership 1.45 %
Institutional ownership 97.40 %
Počet akcií 50.397M
Procento shortovaných akcií 1.41 %
Short ratio 1.96 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2000
Země United States

Finanční výsledky akcie CRL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2,923.933$2,621.226$2,266.096$1,857.601$1,681.432$1,363.302
Cost Of Goods Sold$1,850.392$1,662.915$1,426.029$1,156.683$1,037.473$832.21
Gross Profit$1,073.541$958.311$840.067$700.918$643.959$531.092
Research And Development Expenses------
SG&A Expenses$528.935$517.622$443.854$371.266$364.708$300.414
Other Operating Income Or Expenses------
Operating Expenses$2,491.204$2,270.075$1,934.713$1,569.319$1,443.88$1,156.853
Operating Income$432.729$351.151$331.383$288.282$237.552$206.449
Total Non-Operating Income/Expense$14.385$-47.067$-49.702$8.673$-14.631$-11.021
Pre-Tax Income$447.114$304.084$281.681$296.955$222.921$195.428
Income Taxes$81.808$50.023$54.463$171.369$66.835$43.391
Income After Taxes$365.306$254.061$227.218$125.586$156.086$152.037
Other Income------
Income From Continuous Operations$365.306$254.061$227.218$125.586$156.086$152.037
Income From Discontinued Operations--$1.506$-0.137$0.28$-0.95
Net Income$364.304$252.019$226.373$123.355$154.765$149.313
EBITDA$667.653$549.246$493.162$419.441$364.21$301.33
EBIT$432.729$351.151$331.383$288.282$237.552$206.449
Basic Shares Outstanding504948474746
Shares Outstanding515049494848
Basic EPS$7.35$5.17$4.72$2.60$3.29$3.21
EPS - Earnings Per Share$7.20$5.07$4.62$2.54$3.23$3.13
# 2020 2019 2018 2017 2016 2015
Current Ratio1.43031.43811.60841.78341.5291.7938
Long-term Debt / Capital0.47670.53040.55360.51540.590.5342
Debt/Equity Ratio0.93471.15291.26391.09331.47181.1701
Gross Margin36.715736.559737.071137.732438.298238.9563
Operating Margin14.799613.396514.623515.519114.12815.1433
EBIT Margin14.799613.396514.623515.519114.12815.1433
EBITDA Margin22.834120.953821.762622.579721.660722.103
Pre-Tax Profit Margin15.291511.600812.430215.985913.257814.3349
Net Profit Margin12.45949.61459.98966.64069.204410.9523
Asset Turnover0.53250.55860.58770.6340.620.6591
Inventory Turnover Ratio9.964710.350511.150310.06210.82588.8783
Receiveable Turnover4.73335.09934.79854.31984.61875.048
Days Sales In Receivables77.113671.57876.06584.493879.026872.3059
ROE - Return On Equity17.246315.512117.216411.990218.60120.6136
Return On Tangible Equity150.38931185.914-76191.9871.9154-688.117565.7324
ROA - Return On Assets6.6535.41395.89284.28635.75587.3501
ROI - Return On Investment9.02497.28497.68575.81017.62589.601
Book Value Per Share42.561733.468827.376222.096317.716915.7942
Operating Cash Flow Per Share1.12140.67852.45-0.05820.16631.1399
Free Cash Flow Per Share0.6580.70811.2902-0.60280.34141.009

Porovnání s konkurencí: Akcie CRL

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
CRL 51.53 2.08 19.09 % 10.73 % 18.61 % 9.90 12.46 %
Akcie BASI 0.00 N/A 36.58 % N/A % -42.53 % 22.78 -7.75 %
Akcie BASI 0.00 N/A 36.58 % N/A % -42.53 % 22.78 -7.75 %
Akcie RGEN 143.16 3.82 68.12 % 60.00 % 6.88 % 9.47 16.36 %
Akcie RGEN 143.16 3.82 68.12 % 60.00 % 6.88 % 9.47 16.36 %
Akcie RGEN 143.16 3.82 68.12 % 60.00 % 6.88 % 9.47 16.36 %
Akcie RGEN 143.16 3.82 68.12 % 60.00 % 6.88 % 9.47 16.36 %
Akcie SCYX 0.00 N/A N/A % 153.57 % -197.97 % 4.72 N/A %
Akcie SCYX 0.00 N/A N/A % 153.57 % -197.97 % 4.72 N/A %
Akcie TMO 26.82 7.40 45.73 % -18.29 % 24.87 % 6.59 19.79 %
Akcie TMO 26.82 7.40 45.73 % -18.29 % 24.87 % 6.59 19.79 %

Nedávné obchody insiderů: Akcie CRL

Jméno Obchod Cena Objem
David Ross Smith
Corporate Executive VP and CFO
Option
7 Aug 2020
$144.67 $477,990
Deborah Turner Kochevar
Director
Prodej
7 Aug 2020
$216.24 $501,461
George Massaro
Director
Prodej
7 Aug 2020
$219.91 $427,285
Birgit Girshick
Corporate Executive VP
Prodej
20 Aug 2020
$213.51 $199,205
James C Foster
Chairman, President, and CEO
Prodej
6 Oct 2020
$232.38 $5,112,360
Richard F Wallman
Director
Nákup
2 Nov 2020
$233.20 $1,679,040
David Ross Smith
Corporate Executive VP and CFO
Prodej
4 Jan 2021
$248.76 $1,243,800
James C Foster
Chairman, President, and CEO
Prodej
11 Feb 2021
$285.02 $8,550,600
David Ross Smith
Corporate Executive VP and CFO
Prodej
19 Feb 2021
$290.63 $2,515,693
Michael Gunnar Knell
CSVP and Chief Accounting Officer
Prodej
19 Feb 2021
$290.99 $119,306
Birgit Girshick
Corporate Executive VP
Option
19 Feb 2021
$73.70 $123,448

Diskuze k akciím CRL